It has been found that elevated Th2 cytokines (IL4 and IL13), a hallmark of AD, broadly suppress the expression of barrier-related genes, such as filaggrin, involucrin, and loricrin, through IL-4Rα-STAT6 signaling [59,60,61]. This evidence concerns the gene LORICRIN and Alzheimer disease.